Skip to content

SIR-Spheres® Y-90 resin microspheres

Treatment Access

  • SIR-Spheres® Y-90 resin microspheres have a pre-market approval (PMA) by the FDA and are indicated in the United States for the treatment of unresectable metastatic liver tumors from primary colorectal cancer in combination with intra-hepatic artery chemotherapy using floxuridine.

For further information about the availability of the treatment with SIR-Spheres in your country, please contact us.

Indications for Use: SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intrahepatic artery chemotherapy (IHAC) of FUDR (Floxuridine). Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.